Extendicare (EXE) Competitors

C$7.36
+0.01 (+0.14%)
(As of 10:14 AM ET)

EXE vs. WELL, DR, SIA, DNTL, GUD, ACB, FRX, WEED, KSI, and VHI

Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include WELL Health Technologies (WELL), Medical Facilities (DR), Sienna Senior Living (SIA), dentalcorp (DNTL), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Fennec Pharmaceuticals (FRX), Canopy Growth (WEED), kneat.com (KSI), and Vitalhub (VHI). These companies are all part of the "medical" sector.

Extendicare vs.

Extendicare (TSE:EXE) and WELL Health Technologies (TSE:WELL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation.

Extendicare has a net margin of 2.60% compared to WELL Health Technologies' net margin of 0.01%. Extendicare's return on equity of 36.03% beat WELL Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Extendicare2.60% 36.03% 6.84%
WELL Health Technologies 0.01%2.00%1.88%

In the previous week, WELL Health Technologies had 10 more articles in the media than Extendicare. MarketBeat recorded 10 mentions for WELL Health Technologies and 0 mentions for Extendicare. WELL Health Technologies' average media sentiment score of 0.29 beat Extendicare's score of 0.00 indicating that WELL Health Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Extendicare Neutral
WELL Health Technologies Neutral

21.2% of Extendicare shares are owned by institutional investors. Comparatively, 4.8% of WELL Health Technologies shares are owned by institutional investors. 13.6% of Extendicare shares are owned by insiders. Comparatively, 9.6% of WELL Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Extendicare currently has a consensus price target of C$7.88, indicating a potential upside of 7.00%. WELL Health Technologies has a consensus price target of C$7.39, indicating a potential upside of 104.11%. Given WELL Health Technologies' stronger consensus rating and higher possible upside, analysts plainly believe WELL Health Technologies is more favorable than Extendicare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Extendicare
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
WELL Health Technologies
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Extendicare received 112 more outperform votes than WELL Health Technologies when rated by MarketBeat users. However, 66.10% of users gave WELL Health Technologies an outperform vote while only 49.19% of users gave Extendicare an outperform vote.

CompanyUnderperformOutperform
ExtendicareOutperform Votes
151
49.19%
Underperform Votes
156
50.81%
WELL Health TechnologiesOutperform Votes
39
66.10%
Underperform Votes
20
33.90%

Extendicare has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, WELL Health Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Extendicare has higher revenue and earnings than WELL Health Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareC$1.30B0.47C$33.98MC$0.4018.40
WELL Health TechnologiesC$776.05M1.14-C$7.10MN/AN/A

Summary

Extendicare beats WELL Health Technologies on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXE vs. The Competition

MetricExtendicareMedical Care Facilities IndustryMedical SectorTSE Exchange
Market CapC$612.06MC$1.16BC$4.83BC$5.07B
Dividend Yield6.49%4.03%5.47%6.56%
P/E Ratio18.40268.50173.7526.77
Price / Sales0.4775,134.872,459.371,228.65
Price / Cash3.2012.8145.6877.43
Price / Book6.942.094.663.06
Net IncomeC$33.98MC$34.57MC$102.38MC$293.39M
7 Day Performance0.96%2.38%0.41%1.08%
1 Month Performance-3.79%-2.37%-5.79%14.62%
1 Year Performance12.71%-9.25%9.99%19.97%

Extendicare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WELL
WELL Health Technologies
0.6713 of 5 stars
C$3.50
-0.3%
C$7.39
+111.1%
-35.9%C$859.71MC$776.05M-185.00392
DR
Medical Facilities
0.1704 of 5 stars
C$11.16
+1.5%
C$12.00
+7.5%
+34.7%C$275.88MC$445.58M11.161,833
SIA
Sienna Senior Living
0.686 of 5 stars
C$12.89
-1.4%
C$14.00
+8.6%
+19.9%C$940.58MC$785.37M128.9012,000
DNTL
dentalcorp
1.5392 of 5 stars
C$6.50
-0.2%
C$10.72
+65.0%
-25.8%C$1.17BC$1.43B-14.139,900
GUD
Knight Therapeutics
0.7152 of 5 stars
C$5.77
+0.2%
C$6.58
+14.1%
+20.7%C$583.75MC$328.20M-36.06725
ACB
Aurora Cannabis
0.0983 of 5 stars
C$8.17
-5.3%
C$2.26
-72.3%
+1,101.2%C$445.59MC$275.88M-0.101,130High Trading Volume
FRX
Fennec Pharmaceuticals
0 of 5 stars
C$14.32
+0.8%
N/A+21.1%C$387.21MC$21.25M-14.0429Insider Selling
News Coverage
Positive News
WEED
Canopy Growth
0.0941 of 5 stars
C$9.24
-3.6%
C$3.20
-65.4%
+577.5%C$841.86MC$362.24M-0.432,700Gap Down
KSI
kneat.com
0 of 5 stars
C$3.66
-0.3%
N/A+45.3%C$309.12MC$34.22M-20.33293
VHI
Vitalhub
0.8132 of 5 stars
C$6.35
+5.8%
C$6.42
+1.0%
+134.0%C$277.56MC$52.51M63.50353High Trading Volume

Related Companies and Tools

This page (TSE:EXE) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners